A
Anna Larissa N. Niemeijer
Researcher at VU University Medical Center
Publications - 2
Citations - 439
Anna Larissa N. Niemeijer is an academic researcher from VU University Medical Center. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 2, co-authored 2 publications receiving 192 citations.
Papers
More filters
Journal ArticleDOI
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
Myron G. Best,Nik Sol,Sjors G J G In 't Veld,Adrienne Vancura,Mirte Muller,Anna Larissa N. Niemeijer,Aniko V. Fejes,Aniko V. Fejes,Lee Ann Tjon Kon Fat,Anna E. Huis In ‘t Veld,Cyra E. Leurs,Tessa Y S Le Large,Laura L. Meijer,Irsan E. Kooi,François Rustenburg,Pepijn Schellen,Heleen Verschueren,Edward Post,Laurine E. Wedekind,Jillian Bracht,Michelle Esenkbrink,Leon J Wils,Francesca Favaro,Jilian D. Schoonhoven,Jihane Tannous,Hanne Meijers-Heijboer,Geert Kazemier,Elisa Giovannetti,Jaap C. Reijneveld,Sander Idema,Joep Killestein,Michal Heger,Saskia C.A. de Jager,Rolf T. Urbanus,Imo E. Hoefer,Gerard Pasterkamp,Christine Mannhalter,Jose Gomez-Arroyo,Harm Jan Bogaard,David P. Noske,W. Peter Vandertop,Daan van den Broek,Bauke Ylstra,R. Jonas A. Nilsson,R. Jonas A. Nilsson,Pieter Wesseling,Pieter Wesseling,Niki Karachaliou,Rafael Rosell,Elizabeth Lee-Lewandrowski,Kent B. Lewandrowski,Bakhos A. Tannous,Adrianus J. de Langen,Egbert F. Smit,Egbert F. Smit,Michel M van den Heuvel,Michel M van den Heuvel,Thomas Wurdinger,Thomas Wurdinger +58 more
TL;DR: It is demonstrated that particle-swarm optimization-enhanced algorithms enable efficient selection of RNA biomarker panels from platelet RNA-sequencing libraries to diagnose cancer from TEPs, suggesting that swarm intelligence may also benefit the optimization of diagnostics readout of other liquid biopsy biosources.
Journal ArticleDOI
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
Willemijn S. M. E. Theelen,Dawei Chen,Vivek Verma,Brian P. Hobbs,Heike Peulen,Joachim G.J.V. Aerts,Idris Bahce,Anna Larissa N. Niemeijer,Joe Y. Chang,Patricia M. de Groot,Quynh Nhu Nguyen,Nathan Comeaux,George R. Simon,Ferdinandos Skoulidis,Steven H. Lin,Kewen He,Roshal R. Patel,John V. Heymach,Paul Baas,James W. Welsh +19 more
TL;DR: A pooled analysis was done to infer whether radiotherapy improves responses to immunotherapy in patients with metastatic non-small-cell lung cancer, and best out-of-field (abscopal) response rate (ARR), best abscopal disease control rate (ACR), ARR at 12 weeks, progression-free survival, and overall survival.